Loading...
Avivagen Inc.
VIVXF•PNK
HealthcareDrug Manufacturers - Specialty & Generic
$0.00
$0.00(0.00%)
Avivagen Inc. (VIVXF) Stock Overview
Explore Avivagen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for VIVXFStats details for VIVXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for VIVXFAnalyst Recommendations details for VIVXF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Avivagen Inc., a life sciences company, focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in the United States, Canada, the Philippines, Taiwan, Thailand, China, Mexico, Brazil, and Malaysia. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
CEO
Mr. G. F. Kym Anthony
Employees
13
Headquarters
100 Sussex Drive, Ottawa, ON
Founded
2013